Please ensure Javascript is enabled for purposes of website accessibility
San Diego’s Sorrento Therapeutics Says Antibody Might Have Ability to Fight COVID-19
News
By News
Published 5 years ago on
May 15, 2020

Share

[aggregation-styles]

Sorrento Therapeutics of San Diego said Friday that an antibody it has been developing proved highly effective in blocking the novel coronavirus in laboratory experiments — a possible first step in the creation of a drug cocktail to battle COVID-19.

The antibody, known as STI-1499, performed well even though it was used at a concentration 10- to 100-fold lower than antibodies used to treat other diseases, the company said.

STI-1499 is one of more than a billion antibodies that Sorrento Therapeutics has been examining in an effort to find an effective treatment against a virus that has killed more than 85,000 people in the U.S.

Read More →

RELATED TOPICS:

Search

Help continue the work that gets you the news that matters most.

Send this to a friend